Terms: = Head and neck cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54 AND Treatment
2 results:
1. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for head and neck cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract] [Full Text] [Related]
2. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.
Dardari R; Hinderer W; Lang D; Benider A; El Gueddari B; Joab I; Benslimane A; Khyatti M
J Clin Microbiol; 2001 Sep; 39(9):3164-70. PubMed ID: 11526145
[TBL] [Abstract] [Full Text] [Related]
